ArticleACS omega2025
Bone Regeneration in Rat Calvaria Using 3D-Printed Scaffolds with Graded Porosity and In Vitro Degradation.
Article in ACS omega, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Mechanical forces orchestrate the epigenetic landscape of oral mesenchymal stem/progenitor cell fate in dental and periodontal tissues.Frontiers in cell and developmental biology · 2026Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Craniofacial bone defects present a significant clinical challenge due to their structural complexity and potential neurological implications. In this study, a three-dimensional (3D) polylactic acid (PLA) scaffold with graded porosity and three pore types was fabricated and subjected to a controlled in vitro degradation process. Dental pulp stem cells (DPSCs), which are known for their osteogenic potential, were seeded on the scaffolds to evaluate their osteoconductive performance in a critical-size calvarial defect model in Wistar rats. In vitro assays revealed no significant changes in surface morphology, weight, pH, and mechanical properties over 0, 60, 100, 140, and 180 days of degradation. However, scaffolds degraded for 60 days demonstrated enhanced biological activity in cell-based assays and were therefore selected for in vivo implantation. Microcomputed tomography and bone mineral density analysis indicated that the group receiving degraded scaffolds without cells exhibited the most substantial new bone formation, suggesting effective osteoconductive properties. These findings represent a promising step toward translational medicine and highlight the potential for clinical application, pending further preclinical validation.
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.